Gls Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.30 Cr
as on 26-07-2024
- Paid Up Capital ₹ 1.20 Cr
as on 26-07-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.80 Cr
as on 26-07-2024
- Satisfied Charges ₹ 15.03 Cr
as on 26-07-2024
- Revenue 39.62%
(FY 2023)
- Profit -4.42%
(FY 2023)
- Ebitda 4.59%
(FY 2023)
- Net Worth 141.56%
(FY 2023)
- Total Assets 82.07%
(FY 2023)
About Gls Pharma
The Corporate was formerly known as Gls Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.30 Cr and a paid-up capital of Rs 1.20 Cr.
The company currently has active open charges totaling ₹9.80 Cr. The company has closed loans amounting to ₹15.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suresh Pathak, Srinivasa Ilapakurthy, Debashis Sarkar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TS2004PLC184306
- Company No.
128728
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2004
- Date of AGM
25 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Seri Lingampally, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Gls Pharma Limited offer?
Gls Pharma Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Cancer Injection, Medical Laboratory Instruments, VTM Kit Raw Materials, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines.
Who are the key members and board of directors at Gls Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Pathak  | Managing Director | 01-Sep-2004 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gautam Ghosh | Director | 24-Feb-2021 | Current |
| Srinivasa Ilapakurthy | Additional Director | Current | |
| Debashis Sarkar | Director | 01-Jul-2022 | Current |
| Venkatanarayana Jayampu | Additional Director | 29-Jan-2024 | Current |
Financial Performance of Gls Pharma.
Gls Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.62% increase. The company also saw a slight decrease in profitability, with a 4.42% decrease in profit. The company's net worth Soared by an impressive increase of 141.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gls Pharma?
In 2023, Gls Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 20 Sep 2022 | ₹9.00 Cr | Open |
Icici Bank Limited Creation Date: 11 Jan 2007 | ₹8.00 M | Open |
Canara Bank Creation Date: 30 Aug 2021 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Gls Pharma?
Gls Pharma has a workforce of 116 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gls Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gls Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
